Cornea/External Disease News

NCX 4251 may be effective at reducing dry eye disease symptoms in a specific subgroup of patients, according to a press release from Nicox.

Three topical ophthalmic formulations designed to treat presbyopia demonstrated positive results in the phase 2 VIVID clinical trial, Visus Therapeutics announced in a press release.

As I took a break from packing for my first major meeting in 2 years, I got to thinking about all of the new dry eye disease drugs that would be on stage for the first time in NOLA.

NEW ORLEANS — Patients with dry eye disease saw improvements in symptoms and signs after treatment with varenicline nasal spray, according to a study presented at the American Academy of Ophthalmology meeting.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Greg Kunst, president and CEO of Aurion Biotech, discusses the potential of the company’s technology to work toward cures for corneal endothelial disease.

NEW ORLEANS — Cynthia Matossian, MD, FACS, discussed the value of dry eye diagnostics at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting.

Ideas for this column come from all kinds of places.

Corneal allogenic intrastromal ring segments have been described by Jacob and colleagues for the treatment of keratoconus.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Preeya K. Gupta, MD, discusses tips for clinicians to keep in mind when performing corneal cross-linking.

NEW ORLEANS — Recent years have brought several significant advances in dry eye disease treatment, Amy Lin, MD, said during Cornea Subspecialty Day at the American Academy of Ophthalmology meeting.